Kidney paired donation in the presence of donor-specific antibodies

Kidney International

Volumn 84, Issue 5, 2013, Pages 1009-1016

  Blumberg, Jeremy M ^a   Gritsch, Hans A ^a   Reed, Elaine F ^b   Cecka, J M ^b   Lipshutz, Gerald S ^a   Danovitch, Gabriel M ^a   McGuire, Suzanne ^a   Gjertson, David W ^b   Veale, Jeffrey L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

desensitization; donor specific HLA antibodies; kidney paired donation; living donor kidney transplantation

Indexed keywords

HLA ANTIBODY;

ADULT; ADVERSE OUTCOME; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD GROUP TYPING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HLA TYPING; HUMAN; IMMUNE RESPONSE; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LIVING DONOR; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84888309305     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.206     Document Type: Article

References (34)

1. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735-739.
2. Haririan A, Noqueira J, Kukuruga D et al. Positive cross-match living donor kidney transplantation: longer-term outcomes. Am J Transplant 2009; 9: 536-542.
3. Warren DS, Zachary AA, Sonnenday CJ et al. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant 2004; 4: 561-568.
4. Lefaucher C, Suberbielle-Boissel C, Hill GS et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 2008; 8: 324-331.
5. Reinsmoen NL, Lai C, Vo A et al. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation 2008; 86: 820-825.
6. Zachary AA, Montgomery RA, Ratner LE et al. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 2003; 76: 1519-1525.
7. Vo AA, Toyoda M, Peng A et al. Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIG. Am J Transplant 2006; 6: 2384-2390.
8. Gloor JM, DeGoey SR, Pineda AA et al. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 2003; 3: 1017-1023.
9. Stegall MD, Gloor J, Winters JL et al. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 2006; 6: 346-351.
10. Burns JM, Cornell LD, Perry DK et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008; 8: 2684-2694.
11. Gloor JM, Winters JL, Cornell LD et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch transplantation. Am J Transplant 2010; 10: 582-589.
12. Segev DL, Gentry SE, Warren DS et al. Kidney paired donation and optimizing the use of live donor organs. JAMA 2005; 293: 1883-1890.
13. Montgomery RA, Zachary AA, Ratner LE. Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA 2005; 294: 1655-1663.
14. Rees MA, Kopke JE, Pelletier RP et al. A nonsimultaneous, extended, altruistic donor chain. N Engl J Med 2009; 360: 1096-1101.
15. Gentry SE, Montgomery RA, Swihart BL et al. The roles of dominos and nonsimultaneous chains in kidney paired donation. Am J Transplant 2009; 9: 1330-1336.
16. Bingaman AW, Wright FH, Kapturczac M et al. Single-center kidney paired donation: the Methodist San Antonio experience. Am J Transplant 2012; 8: 2125-2132.
17. Melcher ML, Leeser DB, Gritsch HA et al. Chain transplantation: initial experience of a large multicenter program. Am J Transplant 2012; 12: 2429-2436.
18. Butt FK, Gritsch HA, Schulam P et al. Asynchronous, out-of-sequence, transcontinental chain kidney transplantation: a novel concept. Am J Transplant 2009; 9: 2180-2185.
19. Veale J, Hil G. The National Kidney Registry: transplant chains: beyond paired kidney donation. In: Cecka JM, Terasaki PI (eds) Clinical transplants 2009. Terasaki Foundation Laboratory: Los Angeles, CA, USA, 2009; 253-264.
20. Higgins R, Hathaway M, Lowe D et al. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody. Transplantation 2007; 7: 876-884.
21. Lee PC, Zhu L, Terasaki PI et al. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Transplantation 2009; 88: 568-574.
22. Lee PC, Terasaki PI, Takemoto SK et al. All chronic rejection of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002; 74: 1192-1194.
23. Garća-Ruano AB, Méndez R, Romero JM et al. Analysis of HLA-ABC locusspecific transcription in normal tissues. Immunogenetics 2010; 62: 711-719.
24. Segev DL, Veale JL, Berger JC et al. Transporting live donor kidneys for kidney paired donation: initial national results. Am J Transplant 2011; 11: 356-360.
25. Simpkins CE, Montgomery RA, Hawxby AM et al. Cold ischemia time and allograft outcomes in live donor renal transplantation: is live donor organ transport feasible Am J Transplant 2007; 7: 99-107.
26. Montgomery RA, Katznelson S, Bry WI et al. Successful three-way kidney paired donation with cross-country live donor allograft transport. Am J Transplant 2008; 8: 2163-2168.
27. Waki K, Terasaki PI 2007; Paired kidney donation by shipment of living donor kidneys. Clin Transplant 2007; 21: 186-191.
28. Connolly JS, Terasaki PI, Veale JL. Kidney paired donation: the next step. NEJM 2011; 365: 868-869.
29. Ferrari P, Fuller S, Holdsworth R et al. High transplant rates of highly sensitized recipients with virtual crossmatching in kidney paired donation. Transplantation 2012; 94: 744-749.
30. Zachary AA, Sholander JT, Houp JA et al. Using real data for the virtual crossmatch. Hum Immunol 2009; 70: 574-579.
31. Tait BD, Sü sal C, Gebel HM et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2012; 95: 19-47.
32. Michaels PJ, Espeio ML, Kobashigawa J et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003; 22: 58-59.
33. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753-760.
34. StataCorp. STATA Statistical Software: Release 12. StataCorp LP: College Station, TX, USA, 2011.